Fig 2.tif (219.65 kB)

Eligibility for 12-week simeprevir plus PR regimen according to patient baseline characteristics.

Download (219.65 kB)
figure
posted on 05.01.2017 by Tarik Asselah, Christophe Moreno, Christoph Sarrazin, Michael Gschwantler, Graham R. Foster, Antonio Craxí, Peter Buggisch, Faisal Sanai, Ceyhun Bicer, Oliver Lenz, Gino Van Dooren, Catherine Nalpas, Isabelle Lonjon-Domanec, Michael Schlag, Maria Buti

Eligibility for 12-week simeprevir plus PR regimen according to patient baseline characteristics.

History

Licence

Exports